Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00568243 · ClinicalTrials.gov registry record
Visual Motor Coordination
A clinical trial, sponsored by National Eye Institute (NEI).
- Terminated
- Registry status
- 34
- Enrollment target
NCT00568243: Clinical Trial study, sponsored by National Eye Institute (NEI).
NCT00568243 is a clinical trial that was terminated before completion, run by National Eye Institute (NEI). The registered enrollment target is 34 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00568243 was terminated before completion, sponsored by National Eye Institute (NEI).
- TERMINATED
- Registry status
- 34 participants
- Enrollment target
Study Summary
Background: * The relation between eye movement and brain function is a subject of interest to the National Eye Institute. * By comparing eye movement in healthy volunteers to research conducted on patients who have difficulty moving their eyes, the National Eye Institute hopes to develop and improve diagnostic procedures for people with eye diseases. Objectives: -The purpose of this study is to understand how we see visual patterns and how we move our eyes to see. Eligibility: * Normal volunteers: * must have no serious illnesses and must be 18 years of age or older * are able to follow directions and pay attention to visual stimuli and respond as appropriate * individuals with a history of eye or brain diseases, or previous eye or eye muscle surgery, are not allowed to participate in this study. Individuals who are currently using eye medications also are not eligible for the study. * Patients: * who are 18 years of age or older * are able to follow directions and pay attention to visual stimuli and respond as appropriate Design: * Participants will visit the National Eye Institute outpatient clinic for examination and testing. * Participants will be screened with a medical history and eye examination (including eye pressure and eye movement tests). * Participants with healthy eyes will participate in eye movement testing experiments: * One or more sessions lasting less than three hours each. * Eye movements will be recorded with a video/infrared camera system. * For the majority of the studies done under this protocol, only one or two sessions will be required. A few studies recording very small eye movements will require three or more sessions.
Primary Outcome
Analysis of eye movements to characterize basic processes (normal volunteers) and to judge disease progress (in patients)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2007-12-04 |
| Est. Completion | 2024-04-09 |
Why NCT00568243 stopped before completion
NCT00568243 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 34 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00568243 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00568243 about?
NCT00568243 is a clinical study titled "Visual Motor Coordination". Background: * The relation between eye movement and brain function is a subject of interest to the National Eye Institute. * By comparing eye movement in healthy volunteers to research conducted on patients who have difficulty moving their eyes, the National Eye Institute hopes to develop and impro...
What is the current status of trial NCT00568243?
This trial is currently terminated. The enrollment target is 34 participants. The study started on 2007-12-04. Estimated completion is 2024-04-09.
Who is sponsoring clinical trial NCT00568243?
This trial is sponsored by National Eye Institute (NEI), which has 221 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02897063 · 34 participants · Phase 1
Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
- NCT03906617 · 34 participants · Phase 4
Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine
- NCT03992378 · 34 participants · NA
Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis
- NCT04047849 · 34 participants · Phase 4
Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI